i thought fifty one did a good job of explaining the expected upcoming results....
all clinical trials patients:
- will have a stronger dose of the drug compared to the real life TGA patients,
- have the longer time frame of dosage, being 6 weeks
the 6 weeks seems to be fairly significant, having had the majority of one batch of 25 patients undergo 6 weeks, which had a 60% result of patients experiencing pain reduction...as opposed to the average of 50% to date....with a lot of those patients having shorter treatment than 6 weeks, being estimated at mostly 3-4 weeks..... it really is hard to expect anything other than improvement from the clinical trials... of course, nothing is a given...
i thought fifty one did a good job of explaining the expected...
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 23.0¢ | $85.35K | 365.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 280011 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 44703 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |